ASOs are an effective treatment for disease-associated oligodendrocyte signatures in premanifest and symptomatic SCA3 mice von Schuster, Kristen H., Zalon, Annie J., DiFranco, Danielle M., Putka, Alexandra F., Stec, Nicholas R., Jarrah, Sabrina I., Naeem, Arsal, Haque, Zaid, Zhang, Hanrui, Guan, Yuanfang, McLoughlin, Hayley S.

Volltext